NPs Basic Information

Name
Methyl linolelaidate
Molecular Formula C19H34O2
IUPAC Name*
methyl (9E,12E)-octadeca-9,12-dienoate
SMILES
CCCCC/C=C/C/C=C/CCCCCCCC(=O)OC
InChI
InChI=1S/C19H34O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h7-8,10-11H,3-6,9,12-18H2,1-2H3/b8-7+,11-10+
InChIKey
WTTJVINHCBCLGX-ZDVGBALWSA-N
Synonyms
Methyl linolelaidate; 2566-97-4; Methyl trans,trans-9,12-octadecadienoate; Methyl (9E,12E)-octadeca-9,12-dienoate; Linolelaidic acid, methyl ester; (9E,12E)-Methyl octadeca-9,12-dienoate; 2462-85-3; Methyl octadeca-9,12-dienoate; Linolelaidic acid-methyl ester; 9,12-Octadecadienoic acid, methyl ester, (E,E)-; JRB7ACQ5NW; Linoelaidic acid methyl ester; 9,12-Octadecadienoic acid, methyl ester, (9E,12E)-; (9E,12E)-9,12-Octadecadienoic acid methyl ester; TRANS-9,TRANS-12-OCTADECADIENOIC ACID METHYL ESTER; UNII-JRB7ACQ5NW; Linolelaidic acid methyl ester; UNII-11J6A3P924; 9,12-Octadecadienoic acid, methyl ester; EINECS 219-560-4; EINECS 219-901-7; methyl (9E,12Z)-octadeca-9,12-dienoate; MFCD00069997; AI3-36451; Linolelaidic Methyl Ester; 9,12-OCTADECADIENOIC ACID (Z,Z)-, METHYL ESTER, HYDROPEROXIDE; SCHEMBL813264; SCHEMBL813266; QSPL 074; SCHEMBL17191668; DTXSID90880893; 9,12-octadecadienoic acid methyl; CHEBI:143581; CAA56697; TRANS,TRANS-METHYL LINOLEATE; ZINC3875777; 9,12-Octadecadienoic acid (9Z,12Z)-, methyl ester, hydroperoxide; STL477115; AKOS015902997; 11J6A3P924; Methyl (E, E)-9,12-octadecadienoate; Methyl trans, trans-9,12-octadienoate; 9,12-Octadecadienoicacid, methyl ester; Methyl linolelaidate, analytical standard; 11068-03-4; METHYL (9E,12E)-OCTADECADIENOATE; Methyl 9-trans-12-trans-octadecadienoate; (9E,12E)-Methyloctadeca-9,12-dienoate; Methyl (9E,12E)-9,12-octadecadienoate; M2307; Methyl (9E,12E)-9,12-octadecadienoate #; Methyl linolelaidate, >=99% (GC), liquid; trans-9,12-Octadecadienoic acid methyl ester; (-)-trans-1,2-CyclohexanedicarboxylicAnhydride; T72179; trans-9,12-Octadecadienoic acid, methyl ester; 9,2-Octadecadienoic acid, methyl ester, (E,E)-; A902172; METHYL OCTADECA-TRANS-9-TRANS-12-DIENOATE; (9Z,12E)-9,12-Octadecadienoic acid methyl ester; J-016098; trans,trans-9,12-Octadecadienoic Acid Methyl Ester; trans,trans-octadeca-9,12-dienoic acid methyl ester; Q27281652
CAS 2566-97-4
PubChem CID 5362793
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Fatty Acyls
        • Subclass: Lineolic acids and deriva
          • Direct Parent: Lineolic acids and deriva

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 294.5 ALogp: 6.9
HBD: 0 HBA: 2
Rotatable Bonds: 15 Lipinski's rule of five: Rejected
Polar Surface Area: 26.3 Aromatic Rings: 0
Heavy Atoms: 21 QED Weighted: 0.222

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.796 MDCK Permeability: 0.00003170
Pgp-inhibitor: 0.02 Pgp-substrate: 0.002
Human Intestinal Absorption (HIA): 0.043 20% Bioavailability (F20%): 0.895
30% Bioavailability (F30%): 0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.146 Plasma Protein Binding (PPB): 99.87%
Volume Distribution (VD): 3.059 Fu: 0.86%

ADMET: Metabolism

CYP1A2-inhibitor: 0.814 CYP1A2-substrate: 0.231
CYP2C19-inhibitor: 0.558 CYP2C19-substrate: 0.064
CYP2C9-inhibitor: 0.487 CYP2C9-substrate: 0.974
CYP2D6-inhibitor: 0.628 CYP2D6-substrate: 0.418
CYP3A4-inhibitor: 0.741 CYP3A4-substrate: 0.075

ADMET: Excretion

Clearance (CL): 3.484 Half-life (T1/2): 0.79

ADMET: Toxicity

hERG Blockers: 0.174 Human Hepatotoxicity (H-HT): 0.278
Drug-inuced Liver Injury (DILI): 0.031 AMES Toxicity: 0.002
Rat Oral Acute Toxicity: 0.008 Maximum Recommended Daily Dose: 0.83
Skin Sensitization: 0.966 Carcinogencity: 0.062
Eye Corrosion: 0.918 Eye Irritation: 0.951
Respiratory Toxicity: 0.72
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001605 1.000 D0O1TC 0.685
ENC001714 0.909 D0UE9X 0.603
ENC001645 0.850 D0OR6A 0.602
ENC001435 0.839 D0O1PH 0.537
ENC001583 0.836 D0H2YX 0.388
ENC001535 0.800 D09ANG 0.381
ENC001920 0.800 D0G2MW 0.372
ENC002254 0.791 D07ILQ 0.364
ENC001845 0.767 D09SRR 0.364
ENC001661 0.765 D05ATI 0.354
*Note: the compound similarity was calculated by RDKIT.